Social Behavior: Clinical Trials

9 trials for Social Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 terminated. 9 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Terminated 9
Phase 31Terminated 1

Follow Social Behavior: new trials by email Literature Review of Social Behavior trials Research Report on Social Behavior

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Starting the Conversation
STC - Stigma of Parents of Children With Mental Illness
Phase 2TerminatedUniversity of Ulm52019-10-012021-05-07
To Share Or Not To Share
2Share - History of Suicide Attempt
Phase 2TerminatedUniversity of Ulm42019-05-072020-03-13
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
MP-101, Placebo - Psychosis, Dementia
Phase 2TerminatedMediti Pharma Inc.812017-05-042021-04-01
Oxytocin in Adolescents With Autism Spectrum Disorders
OCYTOCINA - SPRAY NASAL - Autism Spectrum Disorder
Phase 2 / Phase 3TerminatedUniversity of Sao Paulo General Hospital302015-06-012019-10-28
Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation
Eculizumab, Immunoglobulin, Plasmapheresis - Antibody-mediated Rejection, Humoral Rejection
Phase 2TerminatedBrigham and Women's Hospital112013-11-012017-09-21
A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Group 1 ELND005, Group 2 ELND005 - Alzheimer's Disease
Phase 2TerminatedOPKO Health, Inc.2962013-01-012019-10-21
A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age
Recombinant human luteinizing hormone (rhLH), Recombinant follicle-stimulating hormone (rFSH) - Infertility, Ovulation Induction
Phase 2TerminatedMerck KGaA, Darmstadt, Germany762008-11-012014-02-13
A Phase II Study to Assess the Efficacy and Safety of LuverisĀ® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
r-hLH + r-hFSH, r-hFSH, Recombinant Human Choriogonadotropin (r-hCG) - Infertility, Ovulation Induction
Phase 2TerminatedMerck KGaA, Darmstadt, Germany932007-11-012014-02-27
24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
AEB071, mycophenolic plus tacrolimus - Kidney Transplantation
Phase 2TerminatedNovartis Pharmaceuticals1372007-10-012020-12-17

Narrower conditions

Aggression (2)  ·  Alzheimer Disease (2)  ·  Helping Behavior (2)  ·  Infertility (2)  ·  Psychomotor Agitation (2)  ·  Rejection, Psychology (2)  ·  Social Stigma (2)  ·  Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Dementia (1)  ·  Psychotic Disorders (1)  ·  Social Skills (1)

Broader conditions

Behavior (9)  ·  Mental Disorders (3)  ·  Aberrant Motor Behavior in Dementia (2)  ·  Behavioral Symptoms (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Dyskinesias (2)  ·  Genital Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurocognitive Disorders (2)  ·  Neurodegenerative Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Luteinizing Hormone, beta Subunit (2)  ·  Chorionic Gonadotropin (1)  ·  Glycoprotein Hormones, alpha Subunit (1)  ·  Immunoglobulins (1)  ·  Immunoglobulins, Intravenous (1)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1)  ·  LY2812223 (1)  ·  Oxytocin (1)  ·  Plasmapheresis (1)  ·  Tacrolimus (1)  ·  cetrorelix (1)  ·  eculizumab (1)  ·  sotrastaurin (1)

Sponsors

Merck KGaA, Darmstadt, Germany (2)  ·  University of Ulm (2)  ·  Brigham and Women's Hospital (1)  ·  Mediti Pharma Inc. (1)  ·  Novartis Pharmaceuticals (1)  ·  OPKO Health, Inc. (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Spain (4)  ·  United States (4)  ·  Canada (3)  ·  Germany (3)  ·  United Kingdom (2)  ·  Brazil (1)  ·  France (1)  ·  Italy (1)  ·  Switzerland (1)

Top investigators

Anil K Chandraker, MD (1)  ·  Helena P. Brentani, PHD (1)

Results publications

PMID 33884617

NIH funding

2008 (1)